These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 6966764

  • 21. Different effects of serotonin (5-HT) uptake blockers in caudate nucleus and hippocampus of the rabbit: role of monoamine oxidase in dopaminergic terminals.
    Lupp A, Bär KI, Lücking CH, Feuerstein TJ.
    Psychopharmacology (Berl); 1992; 106(1):118-26. PubMed ID: 1738788
    [Abstract] [Full Text] [Related]

  • 22. Effects of antidepressant drug combinations on cortical 5-HT2 receptors and wet-dog shakes in rats.
    Koshikawa F, Koshikawa N, Stephenson JD.
    Eur J Pharmacol; 1985 Dec 03; 118(3):273-81. PubMed ID: 2935412
    [Abstract] [Full Text] [Related]

  • 23. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T, Satoh S, Satoh N, Kisara K, Arai Y, Kim SK, Kinemuchi H.
    J Pharmacol Exp Ther; 1989 Jul 03; 250(1):254-60. PubMed ID: 2501477
    [Abstract] [Full Text] [Related]

  • 24. L-5-HTP facilitates the electrically stimulated flexor reflex in pithed rats: evidence for 5-HT2-receptor mediation.
    Skarsfeldt T, Arnt J, Hyttel J.
    Eur J Pharmacol; 1990 Feb 06; 176(2):135-42. PubMed ID: 1968846
    [Abstract] [Full Text] [Related]

  • 25. Effects of 5-HT receptor subtype-selective drugs on locomotor activity and motor habituation in the DHT adult rat model.
    Pranzatelli MR, Jappay E, Snodgrass SR.
    Pharmacol Biochem Behav; 1987 Jul 06; 27(3):497-504. PubMed ID: 3116560
    [Abstract] [Full Text] [Related]

  • 26. Effect of the selective 5-HT3 receptor antagonists ICS 205-930 and MDL 72222 on 5-HTP-induced head shaking and behavioral symptoms induced by 5-methoxy-N,N,dimethyltryptamine in rats: comparison with some other 5-HT receptor antagonists.
    Shearman GT, Tolcsvai L.
    Psychopharmacology (Berl); 1987 Jul 06; 92(4):520-3. PubMed ID: 3114804
    [Abstract] [Full Text] [Related]

  • 27. Transporter-dependent uptake and metabolism of myocardial interstitial serotonin in the rat heart.
    Sonobe T, Akiyama T, Pearson JT.
    J Physiol Sci; 2022 Oct 26; 72(1):27. PubMed ID: 36289481
    [Abstract] [Full Text] [Related]

  • 28. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA, Johnson JC.
    Eur J Pharmacol; 2004 Mar 19; 488(1-3):201-12. PubMed ID: 15044052
    [Abstract] [Full Text] [Related]

  • 29. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP, Galva MD, Villa F, Sciaba L, Picotti GB.
    Biochem Pharmacol; 1995 Jun 29; 50(1):97-102. PubMed ID: 7605351
    [Abstract] [Full Text] [Related]

  • 30. Monoamine oxidase inhibitory properties of milacemide in rats.
    Truong DD, Diamond B, Pezzoli G, Mena MA, Fahn S.
    Life Sci; 1989 Jun 29; 44(15):1059-66. PubMed ID: 2784529
    [Abstract] [Full Text] [Related]

  • 31. Du 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor.
    Vaatstra WJ, Deiman-Van Aalst WM, Eigeman L.
    Eur J Pharmacol; 1981 Mar 12; 70(2):195-202. PubMed ID: 6973481
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.
    Claassen V, Davies JE, Hertting G, Placheta P.
    Br J Pharmacol; 1977 Aug 12; 60(4):505-16. PubMed ID: 302726
    [Abstract] [Full Text] [Related]

  • 36. Pharmacology of a new phthalane (Lu 10-171), with specific 5-HT uptake inhibiting properties.
    Christensen AV, Fjalland B, Pedersen V, Danneskiold-Samsoe P, Svendsen O.
    Eur J Pharmacol; 1977 Jan 21; 41(2):153-62. PubMed ID: 12988
    [Abstract] [Full Text] [Related]

  • 37. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents.
    Njung'e K, Handley SL.
    Br J Pharmacol; 1991 Sep 21; 104(1):105-12. PubMed ID: 1686200
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R, Salem A, Irvine RJ.
    Clin Exp Pharmacol Physiol; 2007 Oct 21; 34(10):1051-7. PubMed ID: 17714093
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.